News & Views
Scientists discover potential new cancer treatment
Mar 29 2011
Published in BioMed Central's BMC Cancer Journal, the research tracks the use of "artificial plasmid coding for the replicase genes of the Sindbis virus".
Sindbis is an alpha virus that contains on a single strand of RNA its genetic information, something that is replicated into a double strand upon infection.
This is then attacked by the body. Researchers have used this principle to target tumours in mice in a clinical laboratory - and have seen some effect.
Based at the University of Texas in Austin, the researchers saw tumours begin to regress after 25 days.
After 37 days, all tumours were either gone or had begun to shrink.
"In our study both highly immunogenic and poorly immunogenic tumours were receptive to treatment with an RNA replicase based plasmid. Our results suggested a novel approach to cancer molecular therapy," comments Professor Cui.
BMC Cancer is an open access journal, reviewed by peers, publishing research related to all aspects of the illness.
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan